AKT1 and acute respiratory distress syndrome: Shenfu (SF) injection alleviates inflammatory responses, oxidative stress injury, and apoptosis by inhibiting the PI3K/Akt signaling pathway, thereby contributing to the improvement of acute respiratory distress syndrome in septic patients.